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Abstract
Many studies suggest a direct relationship between toxic effects and an increase 
in the p53 protein on cellular DNA. For our studies, we used sperm DNA as an 
indicator of environmental toxic effects, dosing p53 quantitatively. To assess pos-
sible variations, we used semen samples from two homogeneous male groups living 
permanently in areas with different environmental impact. The toxic effects of the 
selected high environmental impact area are caused by both soil and air pollution, 
while the selected low environmental impact area is a nature reserve where there are 
no landfills, but only rural factories. As we work with reproductive cells, our interest 
was inevitably focused on sperm DNA damage and whether this damage could 
affect their fertilizing capacity. The length of telomeres and the quantification of 
protamines are being studied to better define the possible damage.
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1. Introduction
The combination of health and environment is now a major issue on the political 
agenda of many governments because of its social and cultural relevance to both 
individual and collective health.
The World Health Organization (WHO) has set – as one of its main priorities – 
the understanding of the relationship between sources of pollution and the effects 
on health, the development of indicators and the prevention of diseases linked to 
an unhealthy environment, which are a major cause of mortality and morbidity [1] 
Sitography (https://apps.who.int/iris/handle/10665/204585).
Therefore, the ‘eco-epidemiological’ study of the determinants of health and 
their spatial and temporal distribution is of great interest, as these are strongly 
linked to social, cultural and environmental factors that mutually interact and 
affect the genetic heritage of individuals.
To understand which elements should be taken into account, from an epide-
miological point of view, in order to assess the impact of different factors on health 
status is a very complex task.
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The combination of environmental, territorial and epidemiological data, as 
well as other health, demographic, cultural and social indicators, allows us to 
draw up risk thresholds or possible risk scenarios for a specific population (www.
epicentro.iss.it).
It’s now well acknowledged that pollution plays a major role in determining an 
adverse health effect, and that the health condition of the population varies accord-
ing to whether environmental pressure is greater or lower in an area compared to 
another, varying not only over countries, but also within the same country or even 
the same region.
Human semen is an early sensor of the environmental contamination status and 
therefore the first to be affected [2, 3]; Kimberley [4–6].
Chemical substances found in the environment (such as heavy metals and 
dioxins) in food (such as agro-pharmaceuticals or insecticides), as well as unhealthy 
life styles or electromagnetic pollution are the main cause of alterations of semen 
parameters [7, 8]. The well-known mechanisms whereby chemical and physical 
environmental factors, whether combined or not, interfere with reproductive func-
tion are: induction of oxidative stress, hormonal imbalance, genetic and epigenetic 
alterations [9, 10].
Concerning the sperm decline of the last few decades, there is much concern 
among researchers dealing with human reproduction. More specifically, a major 
meta-analysis study on data collected from 1973 to 2011 among the male popula-
tion in Western countries suggest that the concentration of spermatozoa drasti-
cally decreased by more than 50%, from 99 million per milliliter to 47 million 
per milliliter [11] and the situation is certainly no better in some countries such 
as Africa, India, Brazil and China [12–15]. The decline in semen quality seems to 
mirror the impact that pollution and bad lifestyles have had and are still having on 
human health.
Usually, all forms of stress, whether endogenous or exogenous, affecting the 
organism lead to a response from the latter, primarily from the basic morpho-
functional unit, i.e. the cell.
The cell fate decision machinery is composed of multiple complex signaling 
pathways, in which p53 plays a central role in coordinating the multiple cellular 
signaling pathways as well as determining cell fate [16, 17].
When this factor is diverted from its normal control and repair functions, the 
regulation of cell growth may be blocked and the cell rapidly multiplies  
abnormally [18, 19].
The first evidence that p53 could control cell fate was gathered from studies 
using a myeloid leukemia cell line [20]. The finding that p53 can lead to apoptosis 
was confirmed by analogous experiments in which a temperature-sensitive p53 
or WT p53 was also forcibly expressed in erythroleukemia cells [21], in a colon 
cancer cell line [22] and in a Burkitt’s lymphoma cell line [23]. The p53 protein is 
not essential for our survival, but its role in protecting our organism from modified 
cells is crucial, hence the definition of ‘Guardian of the Genome’, referring to its role 
in preserving stability by preventing mutations [24]. Since the biological role of p53 
is to ensure the integrity of the genome in cells, it can stimulate repair processes and 
protective mechanisms, or stop cell division and stimulate induction of cell death 
(apoptosis) [25]. Primarily through its transcription factor function, p53 has the 
ability to induce cell-cycle arrest and apoptosis, both of which protect the cell and 
the organism from DNA damage that leads to genome instability [26]. The activity 
of the p53 protein is stimulated in response to DNA damage and various genotoxic 
insults that ultimately compromise genome integrity [27]. Following genotoxic 
stress, p53 decides cell fate: it may induce growth arrest, DNA repair or, in case of 
exposure to severe DNA damage, even induce cell death by apoptosis. The loss of 
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p53 regulatory functions and activities are involved not only in the development  
of malignant diseases, but also in cardiovascular, neuro-degenerative, infectious 
and metabolic diseases, as well as participating in the aging process of the body. 
p53 is capable of binding specific reactive DNA elements, and the specificity of 
transcriptional activation depends on the ability of the DNA-binding domain and 
p53 protein to interact with the regulatory regions of certain genes. Transcriptional 
activation is determined by the N-terminus of p53, this contains several regions 
which interact with the transcriptional mechanism and recruiting factors that 
modify the local chromatin structure [28]. The p53 protein is mainly regulated by 
post-translational modifications, primarily phosphorylation, and the accumulation 
of p53 is the first step in response to cellular stress [29].
The N-terminus is strongly phosphorylated while the C-terminus contains 
phosphorylated, acetylated and sumoylated residues. N-terminal phosphorylations 
are important for stabilizing p53 and are crucial for acetylation of C-terminal sites, 
which in combination lead to the p53-mediated response to genotoxic stresses [30].
The degradation of p53 depends on the interaction between two proteins and is 
mediated by the proteasome. The link between N-terminal Mdm2 and C-terminal 
p53 leads to the degradation of p53 by Mdm2. Any alterations in the central DNA 
binding domain of p53 do not cancel the sensitivity of the protein to degradation 
mediated by Mdm2 [29, 31, 32].
In response to DNA damage, ATM kinase rapidly phosphorylates p53 at Ser15. 
The serine/threonine kinase Chk2 acts downstream of ATM by phosphorylating p53 
at Ser20. These phosphorylated sites in the N-terminus of p53 are in proximity to 
the Mdm2 binding region of the protein, thus blocking the interaction with Mdm2, 
leading to stabilization of p53, which eludes proteosomal degradation [30]. Recent 
studies suggest that constitutive phosphorylation of p53 by protein kinase inhibits 
the regulation of sequence-specific DNA binding, oligomerisation status, nuclear 
import/export and ubiquitination [30]. Furthermore, constitutive phosphoryla-
tion of p53 by protein kinase C (PKC) at the C-terminal domain contributes to its 
degradation through the ubiquitin-proteasome pathway [33].
We studied the p53 protein by using it as a direct indicator of cellular DNA 
damage caused by environmental toxic factors, comparing levels in male gametes 
(spermatozoa) and associating them with the fertilizing capacity of the spermato-
zoa themselves. On average, it takes 64 days to complete spermatogenesis, but this 
varies from individual to individual. Spermatozoa are produced non-stop every day 
from puberty onwards over a lifetime [34]. This feature could be used to monitor 
changes in environmental impact, drug response (antioxidants) and/or lifestyle. 
Sperm chromatin is very compact and stable in the nucleus, unlike the structure 
of somatic cells. Nuclear condensation in spermatozoa is due to the replacement of 
about 85% of the DNA-associated lysine-rich histones with protamines, arginine-
rich transition proteins [35, 36].
While histones form a ring with DNA (nucleosomes), protamines are bound 
to the grooves of the DNA helix, wrapping tightly around the strands of DNA 
(approximately 50 kb of DNA per protamine) to form tight and highly organized 
rings. Moreover, inter- and intramolecular disulphide bonds between cysteine-rich 
protamines are also responsible for the compaction and stabilization of the sperm 
nucleus [36, 37]. This leads to an extreme nuclear condensation and a reduction of 
about 10% in the size of the nucleus [35]. The BRDT protein (Bromodomain Testis 
specific) is the key protein that mediates chromatin compaction and can facilitate 
nuclear remodeling, thus ensuring the transition between the histone organization 
of the chromatin, or somatic, and the protamine nucleus, typical of the mature 
spermatozoon [38]. Specific nuclear compaction is relevant to protect the sperm 
genome from stressogenic insults. Indeed, both physiological and environmental 
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stress, as well as genetic mutations and chromosomal abnormalities, can interfere 
with the processes of spermatogenesis. These changes can lead to an abnormal 
chromatin structure incompatible with the reproductive plan. The faults of genomic 
material found in mature spermatozoa can impair nucleus formation (defective his-
tone and protamine substitution) and maturation, leading to DNA fragmentation 
(i.e. single- or double-strand breaks) and DNA integrity defects or chromosomal 
aneuploidy in the spermatozoa [36]. In atypical and immature spermatozoa, DNA 
may fragment, lose its functional integrity and thus result in functional defects in 
the spermatozoa. As a matter of fact, DNA fragmentation is particularly common in 
sub-fertile human spermatozoa [36].
p53 is one of the most investigated tumor suppressor proteins and is involved in 
cell cycle regulation, through its effects on transcription regulation in response to 
DNA damage and cell stress, resulting in DNA repair, cellular senescence, growth 
suppression, or apoptosis. Studies also indicate the involvement of p53 in spermato-
genesis [39]. During normal spermatogenesis, p53 is expressed in the intermediate 
layer of the seminiferous tubules, in spermatocytes and round spermatids, suggest-
ing that it might play a role in spermatogenesis [40, 41].
It has actually been suggested that the role of the ancestral p53 gene is to ensure 
the integrity of the genomic germ line and the accuracy of developmental processes 
[42]. The p53 protein fulfills several functions in the meiotic and premeiotic stages 
of spermatogenesis [43]. Possibly, p53 plays different roles in DNA repair, depend-
ing on the type of damage [44], the stage at which the cell was damaged and the 
possible repair pathways available [43]; in short: p53 helps the spermatozoon to deal 
safely with DNA damage [45].
DNA damage, resulting from normal metabolic processes in the cell, occurs at a 
rate of 1000 to one million molecular lesions per cell per day. Nevertheless, several 
causes of damage can increase this rate. Causes of alterations in sperm DNA include 
both extrinsic (environmental and lifestyle factors) and intrinsic causes. Apoptosis, 
or programmed cell death, is a natural process of cells whereby an aged or damaged 
cell dies without damaging its neighbors [46].
As for sperm cells, apoptosis mainly occurs to spermatogonia during spermiohis-
togenesis, a significant factor in blocking the complete development of a damaged 
cell. Apoptosis also occurs in mature spermatozoa when they manifest alterations 
that could be passed on to their offspring or that hinder the normal functions of the 
cell itself [47].
Many studies have been carried out over the years to assess the harmful effects 
of environmental factors on sperm DNA. The first studies were carried out on the 
effects of cigarette smoking and new techniques were developed to highlight the 
damage [48]. When comparing the DNA fragmentation index of spermatozoa from 
smoking and non-smoking patients, researchers were able to determine that the 
DNA damage detected in smokers was greater [49]. DNA breaks can be caused by the 
presence of carcinogens and mutagens in cigarette smoke [50]. Harmful substances, 
including alkaloids, nitrosamines, nicotine, cotinine and hydroxycotinine are found 
in cigarettes and produce free radicals [51]. Kunzle et al. [52], an association between 
cigarette smoking and sperm quality was found among extrinsic causes, i.e. due 
to environmental factors. Rodgman and Perfetti [53] and Alchinbayev et al. [54] 
highlight mutagenic properties of cigarette constituents and altered sperm quality.
Oxidative stress (OS) is the focus of in-depth studies, due to the potential 
harmful effects of high levels of reactive oxygen species (ROS)[55]. An increase in 
leukocytes is supposed to determine an increase in ROS production in semen but the 
process is still not very clear [56].
Environmental toxic effects damage sperm nuclear and mitochondrial DNA. 
The assessment of damage related to non-functional spermatozoa is extremely 
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significant for male fertility [57]. Sperm DNA damage reaches higher levels in 
infertile men than in fertile men and, as a matter of fact, more and more studies 
prove that sperm DNA damage negatively affects reproductive outcomes [58]. 
These damages may not only impair fertility, but also increase the transmission of 
genetic diseases during ART procedures [59]. Spermatozoa produce small amounts 
of ROS and these play a significant role in many sperm physiological processes, such 
as capacitation, hyperactivation and sperm-oocyte fusion [60, 61]. However, ROS 
must be inactivated continuously to keep only a small amount necessary to preserve 
normal cell function. Overproduction of ROS in semen can result in sperm DNA 
damage. An overproduction of ROS in semen can result in sperm DNA.
During their maturation process, spermatozoa extrude their cytoplasm, the main 
source of antioxidants. Once this process is slowed down, the residual cytoplasm forms 
a cytoplasmic droplet in the sperm mid region. These spermatozoa carrying cytoplas-
mic droplets are immature and functionally defective [62]. The residual cytoplasm 
contains a high concentration of certain cytoplasmic enzymes (G6PDH=Glucose-6-
Phosphate DeHydrogenase, SOD= SuperOxide Dismutase), which are also a source 
of ROS [62]. The lack of cytoplasm leads to a decrease in antioxidant defense. This 
process is the link between poor sperm quality and high levels of ROS [56, 63].
Human ejaculate consists of different cell types: mature and immature sperma-
tozoa, round cells from different stages of the spermatogenic process, leukocytes 
and epithelial cells. Peroxidase-positive leukocytes and abnormal spermatozoa 
continuously produce free radicals. Spermatozoa are extremely sensitive to dam-
age caused by excessive ROS because their cytoplasmic membranes contain large 
amounts of polyunsaturated fatty acids (PUFAs), which intensify lipid peroxidation 
by ROS, resulting in a loss of membrane integrity [55, 64, 65]. There is a strong 
positive correlation between immature spermatozoa and ROS production, which in 
turn is negatively connected to semen quality [66]. Moreover, the concentration of 
mature spermatozoa with damaged DNA was found to increase along with imma-
ture spermatozoa in the human ejaculate [47].
Over the last few decades, scientific evidence of the harmful effects on spermato-
genesis of occupational exposure chemicals known as endocrine disruptors (EDCs) on 
the reproductive system has been progressively accumulating [67, 68]. Environmental 
pollution is one of the main sources of ROS production and has been involved in the 
pathogenesis of poor semen quality [69]. A study carried out on workers at motorway 
toll booths, who are constantly exposed to environmental pollutants, correlated blood 
methaemoglobin and lead levels in semen were inversely correlated, compared to local 
male inhabitants not exposed to heavy traffic pollution levels. These results suggest 
that nitrogen oxide and lead, both found in the composition of car exhaust, negatively 
affect semen quality [70]. Furthermore, increased industrialization has led to a high 
deposition of highly toxic heavy metals in the atmosphere. Paternal exposure to 
heavy metals such as lead, arsenic and mercury is associated with a decrease in semen 
parameters, resulting in a reduced fertility capacity [71, 72].
Global pollution was negatively associated with sperm count in a group of 
Californian sperm donors. This study shows a significantly negative relation-
ship between sperm concentration and ozone levels measured 0–9, 10–14 and 
70–90 days prior to semen collection. Since ozone appears not to be involved in 
oxygen transport mechanisms, the mechanism of action remains to be clarified, 
although the observed effect reinforces the evidence on the relationship between 
spermatogenesis and traffic-related pollution [73].
As for pesticides to which the population is exposed or has been exposed in the 
past, the available results of specific studies on their effects on spermatogenesis are 
still inconsistent. This also applies to the well-known DDT, which is now banned 
in Western countries: the effect of this pesticide on spermatogenesis is low [74]. 
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Reproductive capacity, on the other hand, does not seem to be adversely affected 
other than marginally [75, 76].
Similar considerations apply to other persistent contaminants in the environ-
ment. Contrary to this general consideration, an American study reported a highly 
significant association between urinary levels of the metabolites of three pesticides 
and a reduced number of spermatozoa in the ejaculate. However, this study also 
found a decrease in the number of spermatozoa, albeit insignificant [77].
However, Marty et al. [78] found no qualitative differences in the incidence 
of abnormalities in spermatozoa form and number related to p53 concentration, 
in contrast to the data reported by Yin et al. [79]. The latter reported that the p53 
protein controls germ cell quality by inducing spontaneous apoptosis, failure to do 
so results in the accumulation of defective cells, which increases the concentration of 
abnormal spermatozoa and subsequently compromises male fertility. These data are 
supported by more recent studies reporting a negative correlation with nemaspermic 
motility [80]. Sperm vitality correlates strongly with the DNA fragmentation index 
[81] and oxidative stress, caused by harmful environmental exposure, is believed to 
have a significant role in the development and progression of diseases [82].
The function of p53 to govern the fate of cellular life, when it is damaged, is now 
well known. p53 monitoring is useful for assessing the effects of pollutants on DNA. 
Considering the changes of p53 in relation to the degree of the DNA damage, quan-
titative measurement of the p53 protein on sperm DNA was performed to evaluate:
a. possible negative effects of pollutants on male fertility in subjects living in high 
environmental impact area;
b. possible sperm DNA damage following manipulation of spermatozoa during 
the separation procedures for ART techniques, evaluating the quality of the 
embryos too.
For this aim, the method proposed by Raimondo et al. [83] consists of 3 steps:
1. separation of spermatozoa from seminal fluid using a forensic method [84].
2. isolation of nuclear DNA from spermatozoa.
3. quantitative evaluation of the p53 protein by ELISA.
The concentration of the spermatozoa is reported in Mil/ML, 100 micronliters 
of seminal fluid are used for the p53 protein assay, therefore the p53 protein con-
centration is correlated to 1/10 of the sperm count per ML. The correlation existing 
between p53 concentration and number of spermatozoa per ML, allows us to report 
the p53 values in “p53 ng/million spermatozoa” [83].
 
Value of p53ng /100 micronliters
Corrected p53
1/10 of the spermatic count / ml
=
 
p53 protein values are expressed in ng/million spermatozoa.
2. p53 concentration on sperm DNA and environmental impact
The ancestral p53 gene is involved in ensuring the integrity of the genomic 
germline and the replication of developmental processes. The p53 protein is highly 
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expressed in testicles, spermatogonia and primary spermatocytes during pachytene 
or pre-leptotene, when chromosome pairing, recombination and DNA repair occur. 
The expression of p53 at these stages of spermatogenesis suggests that it plays a role 
in meiosis. Apoptosis is a critical process for the integrity of germ cell DNA and in 
regulating their quantity.
If p53 concentrations are not adequate, this would lead to aberrant spermato-
genesis or sperm containing damaged DNA. Failure to control p53 leads to the 
accumulation of defective cells, which increases the concentration of abnormal 
spermatozoa [85] and subsequently impair male fertility. These data are supported 
by more recent studies reporting a negative correlation with nemaspermic motility 
[81, 86]; additionally, sperm vitality is strongly correlated with DNA fragmentation 
index [87, 88].
We carried out an observational study on 117 male subjects, aged 18–38 years 
(28.02 + 4.99), permanently living in low and high environmental impact areas 
from July 2015 to June 2020.
Our purpose is to assess the concentration of the p53 protein on spermatozoa 
DNA using an immunoenzymatic assay (ELISA) as a marker of possible damage. 
The whole group consisted of 117 males divided as follows: 49 of them permanently 
living in low environmental impact areas (southern area of Salerno; Campania, 
Italy), aged 18–38 (28.04 + 4.84) years identified as Group A; 68 of them perma-
nently living in high environmental impact areas (northern area of Naples ‘terra 
dei fuochi’; Campania, Italy), aged 18–37 (28.01 + 5.13) years identified as Group 
B. The observation lasted 60 months, among the requirements: homogeneous 
behavior and lifestyle, no habitual smokers, no alcohol abusers and except for some 
of them who has used cannabis in the past (whose suspension is reported from 6 to 
36 months before the collection of semen), they do not perform activities consid-
ered to be an environmental occupational risk and did not suffer from pathological 
varicocele at preliminary examination with Color Doppler [50, 55, 59, 89, 90].
The examination of the human semen was evaluated using the standardized 
analysis criteria according to the WHO Laboratory Manual for the examination 
and processing of human semen, fifth edition – 2010. In Group A, the ejaculate 
volume ranged from 1.1 to 4.9 mL, and the seminal evaluations were as follows: 
24 samples (48.9%) normospermic; 14 (28.6%) mild oligospermic; 7 (14.3%) 
medium oligospermic; 4 (8.2%) severe oligospermic. In group B, the ejaculate vol-
ume varies from 0.6 to 7.1 ml, the seminal evaluations were as follows: 13 (19.1%) 
normospermic; 20 (29.4%) mild oligospermic; 27 (39.7%) medium oligospermic; 
8 (11.8%) severe oligospermic. The Makler Counting Chamber (Sef-Medical 
Instrumens ltd.) was used to evaluate the nemasperm concentration expressed per 
ml, the number of spermatozoa as well as the study of the non-nemaspermic or 
immature nemaspermic cellular component (leukocytes, red blood cells, germ line 
cells) (Table 1) [49, 53, 91].
Sample processing procedures were carried out 30 minutes after ejaculation. 
Samples were divided into two aliquots, one of which was processed immediately 
for the p53 ELISA assay and the other frozen at −20° for later examination. A 
quantitative assessment of p53 corrected according to the number of spermatozoa 
was performed on all samples and values are expressed in ng/MLN spermatozoa. 
The method employed was that suggested by Raimondo et al. [83].
Data suggest that there are significant differences in seminal parameters from 
groups A and B.
These variations are probably due to the effects of environmental factors 
on the organism, and on semen in particular (Figure 1). This finding is further 
supported by the fact that the examined groups are homogeneous, as previously 
reported.
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Figure 1. 
Significant variations in the main seminal parameters in groups A and B.
Figure 2. 





MLN spermatozoa/mL 41.26 ± 14.6 27.12 ± 9.8
Motility type (a) 33.7 ± 11.5 28.1 ± 9.6
Morfology 15.6 ± 2.8 13.8 ± 3.8
Vitality 61.2 ± 6.3 57.4 ± 8.1
Table 1. 
Description of seminal parameters of the two groups.
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In order to assess the possible damage to the spermatozoa DNA, we used the 
quantitative analysis of the p53 protein and results show a significant variation 
(p < 0.0001) between the two groups: group A; p53= 1.95+1.24: group B; p53= 
6.49+4.29 (Figure 2).
These data highlight that environmental factors are strongly associated with 
seminal parameters alteration and with sperm DNA damage in subjects living in 
high environmental impact areas and, inevitably, these alterations may interfere 
with the reproductive plans of couples living in these areas.
3. p53 concentration on sperm DNA and male fertility
Spermatogenesis is male gametogenesis, i.e. the maturation process of male 
germ cells that takes place in testicles under the stimulus of the hormones FSH and 
testosterone when the individual has reached puberty. Although it’s the equivalent 
of oogenesis in women, it differs from the latter mainly in terms of timing: sperm 
production begins at puberty and lasts a lifetime, oogenesis begins before birth 
and then stops and resumes when the woman reaches sexual maturity, ending at 
menopause. Spermatogenesis is not to be confused with spermiogenesis, which is 
the third and final stage of spermatogenesis, during which the final differentiation 
takes place, leading to the development of mature spermatozoa [92, 93].
At the end of spermatogenesis, only 15–20% of spermatozoa are normal, the 
residual being functionally or morphologically abnormal spermatozoa.
Spermatogenesis takes place inside the testes and more precisely in the seminif-
erous tubules, which are blind-ending tubules that converge in the recti seminifer-
ous tubules. The tubules recti then converge to form the rete testis, from which 15–20 
efferent ducts drain into the epididymis and then continues into the vas deferens. 
The wall of these seminiferous tubules consists of supporting cells, called Sertoli 
cells, and various germ cells that make up the various stages of spermatogenesis. 
The duration of spermatogenesis can take 70 to 90 days and begins with the division 
of undifferentiated cells located near the basal lamina of the seminiferous tubule 
(spermatogonia). These cells undergo mitosis and meiosis, resulting in the produc-
tion of mature cells (spermatozoa) which detach from the most luminal part of the 
tubular wall. Germ cells then undergo a process that brings them from the most 
marginal regions of the wall towards the most apical regions, until they are released 
into the lumen of the tubule. The cells involved in spermatogenesis are divided into 
two large groups: germ cells, consisting of spermatozoa and their precursors, and 
non-germ cells, cells that are not precursors and never become gametes, but have 
trophic and regulatory functions [92, 93]. The primordial germ cells settling in male 
gonads form hollow structures called seminiferous tubules, whose wall consists 
of somatic cells called Sertoli cells. Outside the seminiferous tubule, within the 
connective tissue that surrounds it, there are the Leydig cells, responsible for the 
production of testosterone. In this situation, the germ cells, represented by the A1 
type spermatogonia, which have already undergone a cellular multiplication during 
organogenesis, remain dormant until sexual maturity. The Sertoli cells are tightly 
connected to each other in the basal compartment by occluding junctions that 
together form the blood-testicular barrier. This barrier means that the seminiferous 
tubule is structured into two compartments: the basal compartment (housing the 
spermatogonia and the leptotene spermatocytes) and the adluminal compartment 
(housing the more mature spermatocytes, spermatids and spermatozoa) [94, 95].
The blood-testicular barrier has several functions: it ensures the preservation of 
distinct microenvironments between the two compartments so as to help meiosis 
and spermiohistogenesis in the adluminal compartment and prevent possible 
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immunological responses following exposure to germ antigens or the transit of 
macromolecules from the adluminal compartment into the bloodstream.
The spermatogenesis is a complex process in which differentiation and mitosis of 
a group of starting stem cells take place. The germ cell is called a spermatogonium 
and divides by mitosis into two cells. The first is a differentiated spermatocyte while 
the second maintains the features of spermatogonium, to ensure the turnover of 
the germ cell base [96]. The primary spermatocyte is different from the spermato-
gonium and takes part in the meiosis process. During the first stage, the primary 
spermatocyte (a diploid) divides into two secondary spermatocytes (haploids) con-
taining half the genetic patrimony of the primary spermatocyte. The newly formed 
secondary spermatocyte is still in the meiosis stage and with the second reduction, 
not reducing its genetic patrimony, it divides into two spermatids. Each spermatid is 
then ‘refined’ inside the gonad because it is not yet capable of undergoing fertiliza-
tion. The ‘refining’ is to be understood as a variable length process, aimed at creating 
and reinforcing the structure of the future spermatozoon, which requires particular 
elements that are not present in the spermatids in order to fulfill its task [97]. At the 
final stage, the spermatozoon has a typical structure: mature spermatozoon [98].
The p53 protein was found to have several functions in the meiotic and pre-
meiotic stages of spermatogenesis [99]. Possibly, p53 plays different roles in DNA 
repair, depending on the type of damage, or on the stage at which the cell was 
damaged, and on the possible repair pathways available [42]. The p53 protein helps 
sperm to deal safely with DNA damage [100]. A study by Lane shows that p53 plays 
a role in spermatogenesis: as a matter of fact, mRNA and p53 protein are highly 
expressed during mouse and rat spermatogenesis and we deal with primary pre-
myiotic spermatocytes at the zygotene-pachytene stages, before the beginning of 
meiotic division [101]. In addition, p53-knockout mice and mice with reduced levels 
of p53 show germ cell degeneration during the meiotic prophase, which occurs with 
the appearance of multinucleated giant cells [102]. p53 knockout mice show a higher 
incidence of testicular cancer, suggesting that p53 plays a role in the prevention of 
carcinogenesis during the mitotic stages of spermatogenesis [102–104]. p53 is also 
capable of mediating stress-induced apoptosis of spermatogonia after DNA damage 
and after overheating of testicular tissue [105]. The role of p53 in the stress response 
of spermatogonia is also supported by the extreme reactivity to chemo- and radio-
therapy of testicular cancer cells expressing wild-type p53 [106–108]. This has been 
proven to be the result of the activation of ‘normally latent’ wild-type p53, which 
in turn induces a wide apoptotic response [109]. Several studies report the role of 
the p53 protein in the pre-meiotic and meiotic stages of spermatogenesis [110]. 
Recently, it has been shown that the accuracy of meiotic crossing over at different 
genomic locus does not cause severe difficulties in p53 knockout mice [111], more-
over, the DNA damage in spermatogonia that induces apoptosis is p53 dependent, 
the meiotic quality control of chromosomes at meiotic metaphase I is p53 inde-
pendent. On the other hand, it has been observed that knockout mice for both p53 
and ATM genes proceed to later stages of meiosis than those knockout mice with 
only the ATM gene. Yin et al. [79] reported that p53 mice had impaired apoptosis 
especially in the tetraploid DNA state. These results suggest that DNA damage at the 
meiotic stage is p53 dependent.
The proper presence of the p53 protein in spermatogenesis ensures both the 
quality and the right amount of mature spermatozoa necessary for successful con-
ception. In this observational study, we evaluate the possible correlation between 
p53 concentration on human sperm DNA and male fertility potential.
Our report is based on an observational study involving 169 males over a period 
from March 2014 to February 2019. The whole group consists of 208 male partners 
aged 26–38 years with ejaculate volume from 0.6 to 5.8 ml and heterogeneous 
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seminal evaluation: 86/208 (41.3%) normospermic; 19/208 (9.1%) mild oligosper-
mic; 51/208 (24.5%) moderate to oligospermic; 52/208 (25.1%) with severe oligo-
spermic. The ‘control A’ group includes 39 male partners considered ‘fertile’ because 
we performed the p53 test on their sperm DNA 28 ± 3.5 days after the positive 
pregnancy test results of their partners (betaHCG> 400 m U/mL). Group B, divided 
into B1, B2 and B3, includes 169 male partners and was observed over a period of 
60 months. These partners do not report previous conceptions, do not smoke, do 
not abuse alcohol, do not use drugs and do not suffer from pathological varicoceles 
examined with Color Doppler. The whole group includes married and stable cohab-
iting partners over a period of 27–39 months, reporting frequent unprotected sex. 
The p53 values were corrected with respect to spermatozoa concentration, therefore, 
expressed in ng/million spermatozoa, hence called ‘corrected’ p53 values.
3.1 Results
Group A (39 males) shows ‘corrected’ p53 values ranging between 0.35 and 
3.20 ng/million spermatozoa and group B (169 males) shows values ranging 
between 0.68 and 14.53. In group B over the observation period we recorded 21 
pregnancies with initial ‘corrected’ p53 values ranging from a minimum of 0.84 to a 
maximum of 3.29. In subgroup B1, 8 spontaneous pregnancies were obtained from 
male partners with a ‘corrected’ p53 concentration ranging between 0.84 and 1.34. 
In subgroup B2, 13 pregnancies were obtained from male partners with a ‘corrected’ 
p53 concentration ranging between 1.66 and 3.29. In subgroup B3 (121 males) there 
were neither pregnancies nor miscarriages and the ‘corrected’ p53 values ranged 
between 3.58 and 14.53.
3.2 Conclusion
The results show that participants in group A had ‘corrected’ p53 values between 
0.35 and 3.20 and are considered ‘fertile’, although 3 miscarriages occurred over the 
Figure 3. 
Group A and B with relative “corrected ”p53 concentrations. Spontaneous pregnancies with relative p53 values 
are reported.
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observation period, 36 out of 39 males (92.3%) had a p53 concentration of less than 
1.65. Participants in group B1 had a ‘corrected’ p53 concentration ranging between 
0.84 and 1.34, with 8 pregnancies. In group B2 the ‘corrected’ p53 concentration 
ranged between 1.65 and 3.29 and 13 pregnancies were observed, so this group 
can be considered ‘potentially fertile’. In group B3 (121 males) with ‘corrected’ p53 
values ranging between 3.58 and 14.53, neither pregnancies nor miscarriages were 
observed, so it was considered ‘potentially infertile’ (Figure 3).
4.  p53 concentration on sperm DNA and sperm separation techniques 
(ART)
Many factors damage sperm DNA. Considering an increase in the use of assisted 
reproduction techniques, we would like to assess whether separation techniques can 
be counted among the probable causes of sperm DNA damage. Spermatozoa can be 
isolated for several reasons: for medically assisted procreation (MAP) or diagnostic 
tests [112]. In MAP, the techniques for separating spermatozoa are different and all 
of them aim to improve the pregnancy rate (PR). The need to select/separate sper-
matozoa is necessary in cases of infertility due to reduced seminal parameters or to 
avoid the transmission of sex chromosome diseases. The ideal technique for sepa-
rating spermatozoa should be easy, fast and affordable, should allow the highest 
number of motile spermatozoa to be isolated, should not damage or physiologically 
alter the spermatozoa, should eliminate non-viable spermatozoa, leukocytes and 
bacteria and should allow selection in the event of hyperspermia (increased ejacu-
late volume). Currently, no technique meets all these requirements, so the choice of 
sperm preparation technique is dictated solely by the embryologist’s ability and the 
quality of the semen [113, 114].
The three spermatozoa separation techniques considered in our work are some 
of those reported in the 5th edition of the WHO Laboratory Manual for the exami-
nation of human semen and are also the most frequently used in MAP (Medically 
Assisted Procreation) centres:
4.1 Direct swim-up
This requires semen with parameters at the lower standard limits for sperm 
number and motility and is often used for sperm preparation for intrauterine 
insemination (IUI).
4.2 Pellet swim-up
Exploits the natural ability of spermatozoa to migrate from the seminal plasma 
to the culture medium. This technique is less effective than direct swim-up, but is 
useful when the percentage of motile sperm in the semen is low. Pellet swim-up is 
often used for in vitro fertilization (IVF).
4.3 Density gradient centrifugation
By centrifuging seminal plasma, cells are separated according to their density. 
Moreover, motile spermatozoa actively migrate through the gradient forming a 
pellet at the bottom of the test tube. Usually, a two-layer discontinuous gradi-
ent with 40% density in the upper layer and 80% density in the lower layer is 
used. This technique is mostly used for sperm-deficient ejaculates and for ICSI 
(IntraCytoplasmic Sperm Injection).
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In order to assess whether separation techniques can lead to spermatozoa DNA 
damage, we analyzed samples before and after selection procedures (DGC, pellet 
swim-up and direct swim-up), comparing data with pre-treatment values (control). 
To this end, we used an innovative technique able to quantify spermatozoa DNA 
damage. The reference technique is the one proposed by Raimondo et al. [83], the 
quantitative assessment of p53 protein on spermatozoa DNA corrected for sperm 
concentration. We used an Enzyme-Linked Immunoassay (ELISA), a technique that 
best meets laboratory requirements for accuracy, reliability and repeatability.
4.4 Population enrolled
For this study, we enrolled 63 males in the period from January 2016 to December 
2019, aged 24–31 years, the volume of their ejaculates varies from 2.6 to 4.6 mL and 
have various patterns of dispermia. The sperm evaluations of the subjects were car-
ried out by examining their semen using the standardized analysis criteria accord-
ing to the WHO laboratory manual for the examination and processing of human 
semen, 5th edition, 2010.
The Makler Counting Chamber (Sef-Medical Instrumens Ltd.) was used for the 
assessment of nemaspermic concentration, expressed per mL, as well as for the 
study of the non-nemaspermic cellular component (leukocytes, red blood cells, 
germ line cells) [49, 53, 91].
Enrolled subjects do not suffer from chronic diseases, have not used drugs and 
medications during the 6 months prior to semen collection, are not exposed to 
environmental stress at work [115–117], did not suffer from pathological varicocele 
at preliminary examination with Color Doppler [118–120].
Semen samples were processed when liquefied within 30 to 45 minutes after 
ejaculation.
The samples were then aliquoted into four 0.5 mL aliquots and immediately 
processed.
The four aliquots were processed as follows:
4.5 Group (a): control
Control samples were quantitatively assessed for p53 protein at both 0 and 
60 minutes. During this period of time, semen is not treated, incubated at 37°C at 
5% CO2, in a 15 mL Falcon tube.
4.6 Group (b): direct swim-up
An aliquot of semen is placed under the 300 μL layer of culture medium 
(Quinn’s, SAGE, USA). The test tube is placed at a 45° angle to increase the contact 
surface of semen and medium for 30 minutes at 37° C in a 5% CO2 incubator. The 
supernatant fraction is removed and sent for further assessment [121, 122].
4.7 Group (c): pellet swim-up
A 0.5 mL aliquot of the whole sperm is gently mixed with 1.0 mL of sperm 
culture medium supplemented with 0.1% human serum albumin (Sigma-Aldrich. 
St. Louis, Catalog – A1653), heated to 37° C, in a 15 mL Falcon tube and centri-
fuged at 200 g for 8 minutes. The supernatant is discarded and the precipitate 
(pellet) is mixed with 1.0 mL of culture medium and centrifuged at 100 g for 
45 minutes, the supernatant discarded, 300 micronL of culture medium is gently 
layered onto the final pellet. The test tube is placed at a 45° angle for 30 minutes 
P53 - A Guardian of the Genome and Beyond
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at 37° C in a 5% CO2 incubator. The supernatant fraction is removed and sent for 
further assessment [123, 124].
4.8 Group (d): density gradient centrifugation (DGC)
80/40 gradients (Pureception, SAGE, USA) were placed in 15 mL Falcon tubes, 
followed by layering of 0.5 mL of whole ejaculate and then centrifuged at 200 g 
for 20 minutes. The gradient is removed and the pellet is washed twice (200 g x 
5 minutes) with 1.0 mL of culture medium. The final pellet is layered on the surface 
with 300 μL of culture medium and placed at 37°C in a 5% CO2 incubator for 
30 minutes. The supernatant fraction is removed and sent for further assessment 
[125, 126].
All samples are subjected to a quantitative assay of p53 protein corrected in rela-
tion to the number of spermatozoa.
Separation of spermatozoa is an important step in ART techniques. Our data 
show that the Density Gradient Centrifugation (Group d) and Direct Swim-up 
(Group b) techniques provide superior quality in terms of motility, vitality and 
apoptosis indices compared to other conventional techniques. In Group (b), apop-
tosis is superimposable to that of Group (d), while motility and vitality are slightly 
lower. Group (c) has lower parameters than the other techniques. With regard to 
the assessment of the p53 protein, the results are in contrast with those of apop-
tosis: in Group (d), the values are significantly higher than the other techniques 
(Table 2).
The mean percentage of apoptotic spermatozoa in the processed samples was 
evaluated by the AO test [48] and samples processed by pellet Swim-up (Group 
c) were found to be significantly higher than those processed by density gradi-
ent (Group d) and direct Swim-up (Group b). The lower percentage of apoptotic 
spermatozoa found in Group (b) and Group (d) suggest that these techniques result 
in a supernatant with fewer spermatozoa with fragmented DNA. The use of apop-
totic spermatozoa during ART may be one of the causes of failure of MAP cycles. 
The negative association between sperm apoptosis and fertilization rate has been 
documented with several studies [127, 128]. The selection of non-apoptotic sper-
matozoa should be one of the most important requirements for achieving optimal 
conception rates in ARTs [128]; it is beyond doubt that to achieve this important 
parameter, it is necessary to choose a separation technique that comes closest to 
natural selection.
This work suggests that the spermatozoa preparation techniques commonly 
used for assisted reproduction techniques result in different levels of apoptosis 
and spermatozoa DNA damage, which can be assessed by quantifying the p53 
protein isolated from spermatozoa DNA. In the future, we plan to use p53 quan-
tization to assess the damage already existing in spermatozoa DNA of potential 
P53 ng/Mln spermatozoa
Before After P value
Control 2,72 ± 0,0 3,17 ± 2,1 NS
Direct swum-up 2,72 ± 0,3 3,18 ± 2,9 NS
Pellet swim-up 2,72 ± 0,2 4,02 ± 3,2 P<0,001
Density gradient centrifugation 2,72 ± 0,3 7,87 ± 3,9 P< 0,0001
Table 2. 
Variation in p53 protein concentrations, before and after the separation technique used, including statistical 
changes.
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patients wishing to undergo assisted reproduction techniques, so as to prevent the 
final result from being further compromised. In case the p53 concentration in the 
untreated samples is already high, a possible therapy could be evaluated for such 
patients to improve the starting conditions of spermatozoa thus achieving a better 
result [5, 6]. This work fits well into a scenario of spermatozoa quality assessment 
and the importance of having an objective and repetitive data prior to conception 
both in vivo and in vitro [129].
5. p53, embryo quality and pregnancy rate
The p53 protein is thought to play an important role in oocyte maturation, 
blastocyst development and embryo implantation in human reproduction [130].
p53 protein expression is low in zygotes and at the cleavage stage, but then 
increases around the blastocyst stage. Blastocysts from in vivo fertilization have 
low concentrations of p53 protein, while p53 expression is higher in embryos 
produced by in vitro fertilization. These findings suggest that embryo culture leads 
to accumulation of p53 protein transcription activity in blastocysts and may be 
one of the reasons for the delayed growth of embryos. Human embryos generated 
by intracytoplasmic sperm injection (ICSI) have a high nuclear p53 expression, 
associated with delayed embryo development [131]. From these considerations, a 
more complex role for the p53 protein emerges, which is different from just control-
ling the integrity of sperm DNA; it is assumed to control the timing and mode of 
embryo development [132].
The p53 protein plays an important role in the cell and is normally found in all 
cell types in the human body. It plays a central role in an extensive control network 
of proteins that enable the ‘healthy’ condition of a cell and of cellular DNA. The 
p53 protein is the ‘director’ of a well-orchestrated cell damage detection and control 
system. When damage occurs, the activity of the p53 protein is crucial in deciding 
whether to repair it or induce cell death. The death of a cell that has suffered severe 
DNA damage is vital for the organism because it prevents the reproduction of cells 
with dangerous and harmful mutations and, in the event of conception, prevents 
abnormal embryonic development [133].
Its increase is proportional to cellular damage, so its quantitative assessment 
indicates DNA damage. Also interesting is its role in controlling and regulating 
the meiosis process of spermatogenesis and its function in monitoring embryonic 
development.
The idea that the p53 protein performs multiple tasks in systemic cellular control 
and development and in the control of human reproductive project is gaining 
momentum. Our work fits well with the knowledge of the presence of the p53 
protein in differentiating male fertility.
For our study, we enrolled 117 partners of couples who had undergone medi-
cally-assisted procreation (MAP) for conception.
The seminal parameters were assessed according to the criteria of the WHO 
2010 manual, shown in Table 3.
Participants were assessed for the concentration of the p53 protein on sperm 
DNA, first proceeding to a DNA extraction using a forensic method and then to a 
quantization of the p53 protein using ELISA-immunoassay technique, with another 
calculation of the results, and expressed in ng/MLN spermatozoa [83].
The embryologist chose the MAP technique to be performed, based on the seminal 
parameters obtained after the capacitation procedure and, in order to ensure consis-
tency in comparison, it was the same for all samples (Percoll gradients): 90 couples 
(76.9%) using the IVF technique and 27 couples (23.1%) using the ICSI technique.
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IVF stands for In Vitro Fertilization with Embryo Transfer and is the first arti-
ficial insemination technique used. IVF is recommended for couples with proven 
fertility problems: for women, especially those suffering from tubal pathologies 
(obstruction of the fallopian tubes), and for men when there are minor problems 
with the semen. This technique can be used mainly in patients who have already 
conceived naturally, because the ability of the sperm to spontaneously penetrate 
the egg cell is more certain. With IVF (or in vitro fertilization), conception takes 
place outside the woman’s body: the sperm spontaneously penetrate the egg cell, but 
everything takes place in a test tube.
ICSI stands for IntraCytoplasmic Sperm Injection and is used in patients of 
advanced maternal age (>36 years), in cases where oocyte production is low or, 
1.145 < p53 > 2.45 ng/Mln 
spermatozoa
3.20 < p53 > 7.75 ng/Mln spermatozoa
Participants 51 66
No. MII oocytes 380 257
Embryos 248 (65.4%) 104 (40.5%)
Pregnancies 28 (PR=54.9%) 13 (PR=19.7%)
Table 4. 
Number of participants, number of total (MII) oocytes, number of embryos that reached the 6–8 cell stage, 
pregnancies achieved (PR) for two groups of p53 values.
Participants MLN spermatozoa/mL Type a 
motility %
Morfology % according 
to Kruger
Vitality %
117 20,14 ↔ 48,31 18,5 ↔ 51,6 8,5 ↔ 17,8 48,8 ↔ 76,5
Table 3. 
Seminal parameters of the participants.
Figure 4. 
Interrelation between p53 concentration, embryonic development and PR.
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in the case of men, if there is severe seminal damage, such as the total absence of 
spermatozoa in the ejaculate fluid and it is necessary to proceed with the aspiration 
of sperm directly from the testicle.
The initial phase of ICSI is the same as that of IVF, starting with hormonal 
stimulation and then moving on to oocyte aspiration. The difference is that in ICSI 
a spermatozoon is selected by the biologist and injected into the cytoplasm of an 
oocyte using a micro needle to ‘force’ fertilization. This operation is repeated for all 
the oocytes to be inseminated. The following stages are exactly the same as IVF.
On the third day of embryo development, the number of embryos that reached 
the stage of 6–8 was assessed. Pick-up report (IVF + ICSI), fertilization and 
Pregnancy rate (PR) are shown in Table 4.
The results obtained support the theory that a high concentration of the p53 
protein in spermatozoa DNA is associated with a low percentage of embryos able to 
reach the 6–8 cell stage on day three and a lower pregnancy rate (Figure 4).
Our work fits well with prediction models and the importance of having objec-
tive and repetitive data prior to conception, both in vivo and in vitro [134].
6. Conclusions
Cytochemistry, fluorescence and electrophoresis techniques have so far been 
used to assess DNA damage. For our studies, we employed an innovative method 
called ‘quantitative proteomics’, an analytical chemical technique for determining 
the amount of protein in a given sample. The methods for identifying proteins 
are identical to those used in general proteomics, but include quantification as an 
additional dimension. We used p53, a protein already known as the ‘guardian of 
the genome’, to assess the effect of environmental and/or dietary toxic factors on 
human bodies through DNA damage. From our studies, we have identified the 
spermatozoon as a sentinel cell of environmental impact, as its DNA damage is 
strongly correlated with pollution. Inevitably, the evolution of these preliminary 
Figure 5. 
Schematic representation of the effects of the different concentrations of the p53 protein on human 
reproduction.
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studies turned to understanding whether DNA damage could influence the fertil-
izing capacity of males. We think that given our results, this protein can be used 
as an indicator of environmental impact, and given the renewal characteristics 
of spermatogenesis, it can also be used as a prevention and follow-up index for 
environmental remediation. A more extensive use would be to understand whether 
sperm DNA is compatible with the couple’s optimal reproductive project both in 
vivo and in vivo (Figure 5).
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
19
Presence of p53 Protein on Spermatozoa DNA: A Novel Environmental Bio-Marker and…
DOI: http://dx.doi.org/10.5772/intechopen.99559
References
[1] Prüss-Ustün A., Wolf J., Corvalán CF., 
Bos R., Neira MP. Preventing disease 
through healthy environments: a global 
assessment of the burden of disease from 
environmental risks. 2016 World Health 
Organization
[2] Olea N., Fenandez MF. Chemicals  
in the environment and human male 
fertility. 2007 Occup Environ Med 
64(7): 430-431
[3] Stachel B., Dougherty RC., Lahl U., 
Schlosser M., Zeschmar B. Toxic 
environmental chemicals in human 
semen: analytical method and case 
studies.1989 Andrologia;21(3):282-91
[4] Kimberley Bryon-Dodd. 
Environmental chemicals affect sperm 
epigenetics. BioNews 2017
[5] Montano L., Bergamo P., 
Andreassi MG., Lorenzetti S. The role of 
human semen as an early and reliable tool 
of environmental impact assessment on 
human health. Full Chapter in Final Book 
Title & ISBN: Spermatozoa – Facts and 
Perspectives. 2018a InTechOpen; 73231
[6] Montano L., Raimondo S., 
Gentile M., Notari T., Bifulco R., 
Porciello G., Gentile T. The role of 
synergic action between alpha-tocoferol 
and lifestyle on reduction of p53 protein 
in human spermatozoa (preliminary 
data. EcoFoodFertility). 2018b Reprod 
Toxicol; 80:29-30
[7] Mima, M., Greenwald, D. & Ohlander, 
S. Environmental Toxins and Male 
Fertility. 2018 Curr Urol Rep 19, 50
[8] Perheentupa A. Male infertility and 
environmental factors. 2019 Global 
Reproductive Health; 4(2) e28
[9] Sengupta P., Banerjee R. 
Environmental toxins: Alarming 
impacts of pesticides on male fertility. 
2013 Human & Experimental 
Toxicology; 33(10): 2017-1039
[10] Tang Q., Wu W., Zhang J., Fan R., 
Liu Mu. Environmental factors and  
male Infertility 2018. DOI 10.5772 
Interchopen. 71553
[11] Levine H., Jorgensen N., 
Martino-Andrade A., Memdiola J., 
Weksler-Derri D., Mindlis I., Pinotti R., 
Swan SH. Temporal trends in sperm 
count: a systematic rewiew and meta-
regression analysis. 2017 Hum Reprod 
Update. 1; 23(6): 646-659
[12] Mishra, P., Negi, M.P.S., Srivastava, 
M.et al., Decline in seminal quality in 
Indian men over the last 37 years. 2018 
Reprod Biol Endocrinol;16,103
[13] Sengupta P., Borges E. Jr, Dutta S., 
Krajewska-Kulak E. Decline in sperm 
count in European men during the past 
50 years. 2018 Hum Exp Toxicol;37(3): 
247-255
[14] Siqueira, S., Ropelle, A.C., 
Nascimento, J.A.A. et al., Changes in 
seminal parameters among Brazilian men 
between 1995 and 2018. 2020 Sci Rep;10: 
6430
[15] Yuan HF., Shangguan HF., Zheng Y., 
Meng TQ., Xiong CL., Guan HT. Decline 
in semen concentration of healthy 
Chinese adults: evidence from 9357 
participants from 2010 to 2015. 2018 
Asian J Androl;20(4):379-384
[16] Levine AJ., Oren M. The first 30 years 
of p53: Growing ever more complex. Nat. 
Rev. Cancer. 2009;9:749-758
[17] Luo Q, Beaver JM, Liu Y, Zhang Z. 
Dynamics of p53: A master decider of 
cell fate. Genes (Basel). 2017;8(2):66
[18] Hanna K., Coussen C. Rebuilding 
the Unity of Health and Environmental: 
A New Vision of Environmental Health 
for the 21st Century. Washington, D.C.: 
National Academies Press, 2001
P53 - A Guardian of the Genome and Beyond
20
[19] Koren HS., Butler CD. The 
interconnection between the built 
environment ecology and health. In: 
Morel B., Linkov I. (eds) Environmental 
Security and Environmental Manage-
ment: The Role of Risk Assessment. 
NATO Security through Sciences Series, 
vol5. Springer Dordrecht, 2006
[20] Yonish-Rouach E., Resnitzky D., 
Lotem J., Sachs L., Kimchi a. Oren M. 
wild-type p53 induces apoptosis of 
myeloid leukaemic cells that is inhibited 
by interleukin-6. 1991 Nature;352(6333): 
345-347
[21] Johnson P., Chung S., Benchimol S. 
Growth suppression of friend virus-
transformed Erythroleukemia cells by p53 
protein is accompanied by Hemoglobin 
production and is sensitive to erythro-
poietin. 1993 Mol Cell Biol;Vol. 13, No. 3 
1456-1463
[22] Shaw P., Bovey R., Tardy S., Sahli R., 
Sordat B., Costa J. Induction of apoptosis 
by wild-type p53 in a human colon 
tumor-derivedcellline 1992 
Biochemistry;89:4495-4499
[23] Ramqvist T., Magnusson KP., 
Wang Y., Wiman KG. et al., Wild-type 
p53 induces apoptosis in a Burkitt 
lymphoma (BL) line that carries mutant 
p53. 1993 Oncogene;8(6):1495-500
[24] Okamura S., Arakawa H.,  
Tanaka T., Nakanishi H., Ng CC., 
Taya Y., Monden M., Nakamura Y. 
p53DINP1, a p53-inducible gene, 
regulates p53-dependent apoptosis.2001 
Mol. Cell; 8(1): 85-94
[25] Aubrey BJ., Kelly GL., Janic A., 
Herold MJ., Strasser A. How does p53 
induce apoptosis and how does this 
relate to p53-mediated tumour 
suppression? 2018 Cell Death and 
Differentiation;25:104-113
[26] Eischen CM, Lozano G. The Mdm 
network and its regulation of p53 
activities: A rheostat of cancer risk. 
Hum Mutat 2014; 35: 728-737
[27] Horn HF, Vousden KH. Coping with 
stress: Multiple ways to activate p53.
Oncogene 2007; 26: 1306-1316
[28] Harris SL, Levine AJ. The p53 
pathway: Positive and negative feedback 
loops.Oncogene 2005; 24: 2899-2908
[29] Oren M. Regulation of the p53 
tumor suppressor protein. 1999 J Biol 
Chem;274: 36031-36034
[30] Appella E., Anderson CW. Post-
translational modifications and 
activation of p53 by genotoxic stresses. 
2001 Eur J Biochem; 268: 2764-2772
[31] Kubbutat MH., Vousden KH. 
Keeping an old friend under control: 
Regulation of p53 stability. 1998 Mol 
Med Today; 4: 250-256
[32] Ryan KM, Phillips AC, Vousden KH. 
Regulation and function of the p53 
tumor suppressor protein. 2001 Curr 
Opin Cell Biol; 13: 332-337
[33] Yoshida K, Miki Y. The cell death 
machinery governed by the p53 tumor 
suppressor in response to DNA damage. 
Cancer Sci 2010;101(4):831-835
[34] Heller CG., Clermont Y. Spermato-
genesis in man: an estimate of its 
duration. 1963 Science; 140 (3563):  
184-186
[35] Aoki VW., Moskovtsev SI., Willis J., 
Liu L., Mullen JB., Carrell DT. DNA 
integrity is compromised in protamine-
deficient human sperm. 2005 J 
Androl;26:741-748
[36] Aziz N., Agarwal A. Evaluation of 
sperm damage: Beyond the World 
Health Organization criteria. Fertil 
Steril 2008;90:484-485
[37] Kosower NS., Katayose H., 
Yanagimachi R. Thioldisulfide status 
and Acridine Orange fluorescence of 
mammalian sperm nuclei. 1992 J 
Androl;13:342-348
21
Presence of p53 Protein on Spermatozoa DNA: A Novel Environmental Bio-Marker and…
DOI: http://dx.doi.org/10.5772/intechopen.99559
[38] Pivot-Pajot C., Caron C., Govin J., 
Vion A., Rousseaux S., Khochbin S. 
Acetylation-dependent chromatin 
reorganization by BRDT, a testis-
specific bromodomain-containing 
protein. 2003 Mol Cell Biol;23:5354-5365
[39] Marcet-Ortega M., Pacheco S., 
Martínez-Marchal A., Castillo H., 
Flores E., Jasin M., Keeney S., Roig I.  
p53 and TAp63 participate in the 
recombination-dependent pachytene 
arrest in mouse spermatocytes. PLOS 
Genetics 2017;13(6): e1006845
[40] Bornstein C., Brosh R., 
Molchadsky A., et al., SPATA18, a 
spermatogenesis-associated gene, is a 
novel transcriptional target of p53 and 
p63. Mol Cell Biol. 2011;31:1679-1689
[41] Zalzali H., Rabeh W., Najjar O., 
Ammar RA., Harajly M., Saab R. 
Interplay between p53 and Ink4c in 
spermatogenesis and fertility, Cell Cycle 
2018; 17(5): 643-651
[42] Toyoshima M. Analysis of p53 
dependent damage response in sperm 
irradiated mouse embryos. 2009 J 
Radiat Res; 50:11-17
[43] Marty SM., Singh NP., Stebbins KE., 
Ann Linscombe V., Passage J., Bhaskar 
Gollapudi B. Initial insights regarding 
the role of p53 in maintaining sperm 
DNA integrity following treatment of 
mice with ethylnitrosourea or cyclo-
phosphamide. 2010 Toxicol Pathol;38: 
244-257
[44] Tang W., Willers H., Powell SN. p53 
directly enhances rejoining of DNA 
double-strand breaks with cohesive ends 
in gamma-irradiated mouse fibroblasts. 
1999 Cancer Res;59:2562-2565
[45] Riley T., Sontag E., Chen P., 
Levine A. Transcriptional control of 
human p53-regulated genes. 2008 Nat 
Rev Mol Cell Biol;9:402-412
[46] Nagata S. Apoptosis by death factor. 
Cell. 1997;88(3):355-365
[47] Gil-Guzman E., Ollero M., 
Lopez MC., Sharma RK., Alvarez JG., 
Thomas AJ Jr. Differential production of 
reactive oxygen species by subsets of 
human spermatozoa at different stages 
of maturation. Hum Reprod. 2001;16: 
1922-1930
[48] Tejada RI., Michell JC., Norman A., 
Marik JJ., Friedman S. a test for the 
practical evaluation of male fertility by 
Acridine Orange (AO) fluorescence. 
1984 Fertil Steril; 42(1): 87-91
[49] Penn DJ., Potts WK. The evolution 
of mating preferences and major 
histocompatibility complex genes. 1999 
American Naturalist;153 (2):145-164
[50] Otts RJ., Newbury CJ., Smith G., 
Notarianni LJ., Jefferies TM. Sperm 
chromatin damage associated with male 
smoking. 1999 Mutat Res; 423: 103-107
[51] Traber MG., van der Vliet A., 
Reznick AZ., Cross CE. Tobacco-related 
diseases. Is there a role for antioxidant 
micronutrient supplementation? 2000 
Clin Chest Med; 21: 173-187
[52] Kunzle R., Mueller MD., Hanggi W., 
Birkhauser MH., Drescher H., 
Bersinger NA. Semen quality of male 
smokers and nonsmokers in infertile 
couples. Fertil Steril. 2003; 79: 287-291
[53] Rodgman A., Perfetti T.O. The 
Chemical Components of Tobacco and 
Tobacco Smoke. 2013, II edition. CRC 
Press, Taylor and Francis Group
[54] Alchinbayev MK., Aralbayeva AN., 
Tuleyeva LN. Aneuploidies level in 
sperm nuclei in patients with infertility. 
Mutagenesis 2016 Sep;31(5):559-565
[55] Federico A, Morgillo F, Tuccillo C, 
Ciardiello F, Loguercio C. Chronic 
inflammation and oxidative stress in 
human carcinogenesis. Int J Cancer. 
2007;121(11):2381-6.
[56] Aitken RJ., West KM. Analysis of the 
relationship between reactive oxygen 
P53 - A Guardian of the Genome and Beyond
22
species production and leucocyte 
infiltration in fractions of human semen 
separated on Percoll gradients. Int J 
Androl. 1990; 13: 433-451
[57] Park J-H., Zhuang J., Li J., 
Hwang PM. p53 as guardian of the 
mitochondrial genome. 2016 FEBS Lett; 
590(7): 924-934
[58] Raimondo S., Gentile T.,  
Gentile M., et al., P53 protein evaluation 
on spermatozoa DNA in fertile and 
infertile males. J Hum Reprod Sci 
2019;12(2):114-121
[59] Cocuzza M., Sikka SC., Athayde KS., 
Agarwal A. Clinical relevance of oxidative 
stress and sperm chromatin damage in 
male infertility: an evidence based 
analysis. 2007 Int Braz J Urol;33(5):603-21
[60] Lewis SE., Boyle PM., 
McKinney KA., Young IS., Thompson W. 
Total antioxidant capacity of seminal 
plasma is different in fertile and infertile 
men. Fertil Steril. 1995; 64: 868-870
[61] Sies H. Strategies of antioxidant 
defense. Eur J Biochem. 1993; 215(2):  
213-219
[62] Huszar G., Sbracia M., Vigue L., 
Miller DJ., Shur BD. Sperm plasma 
membrane remodeling during 
spermiogenetic maturation in men: 
Relationship among plasma membrane 
beta 1,4-galactosyltransferase, 
cytoplasmic creatine phosphokinase, 
and creatine phosphokinase isoform 
ratios. Biol Reprod. 1997; 56: 1020-1024
[63] Hendin BN., Kolettis PN., 
Sharma RK., Thomas AJ Jr., Agarwal A. 
Varicocele is associated with elevated 
spermatozoal reactive oxygen species 
production and diminished seminal 
plasma antioxidant capacity. 1999 J Urol; 
161: 1831-1834
[64] Buettner GR. The pecking order of 
free radicals and antioxidants: Lipid 
peroxidation, alpha-tocopherol, and 
ascorbate. Arch Biochem Biophys. 1993; 
300: 535-543
[65] Halliwell B. How to characterize a 
biological antioxidant. Free Radic Res 
Commun. 1990; 9: 1-32
[66] Gomez E., Irvine DS., Aitken RJ. 
Evaluation of a spectrophotometric 
assay for the measurement of 
malondialdehyde and 4-hydroxyalkenals 
in human spermatozoa: Relationships 
with semen quality and sperm function. 
Int J Androl. 1998; 21: 81-94
[67] Bosco L., Notari T., Rovolo G., 
Roccheri M., Martino C., Chiappetta R., 
Carone D., Lo Bosco G., Carillo L., 
Raimondo S., Guglielmino A., 
Montano L. Sperm DNA fragmentation: 
An early and reliable marker of air 
pollution. Environ Toxicol Pharmacol 
2018;58:243-249
[68] Kumar S. Occupational exposure 
associated with reproductive 
dysfunction. J Occup Health. 2004; 
46: 1-19
[69] Gate L., Paul J, Ba GN, Tew KD, 
Tapiero H. Oxidative stress induced in 
pathologies: the role of antioxidants. 
1999 Biomed Pharmacother;53(4):169-80
[70] De Rosa M., Zarrilli S., Paesano L., 
Carbone U., Boggia B., Petretta M., et al.,: 
Traffic pollutants affect fertility in men. 
Hum Reprod. 2003; 18(5): 1055-1061
[71] Sallmen M., Lindbohm ML., 
Anttila A., Taskinen H., Hemminki K. 
Time to pregnancy among the wives of 
men occupationally exposed to lead. 
Epidemiology. 2000a; 11: 141-147
[72] Sallmen M., Lindbohm ML., 
Nurminen M. Paternal exposure to lead 
and infertility. Epidemiology. 2000b; 
11: 148-152
[73] Sokol RZ., Kraft P., Fowler IM., 
Mamet R., Kim E., Berhane KT. 
Exposure to environmental ozone 
23
Presence of p53 Protein on Spermatozoa DNA: A Novel Environmental Bio-Marker and…
DOI: http://dx.doi.org/10.5772/intechopen.99559
affects semen quality. Environ Health 
Perspect. 2006; 114: 360-365
[74] Dalvie MA., et al., The long-term 
effects of DDT exposure on semen, 
fertility and sexual function of malaria 
vector-control workers in Limpopo 
Province, South Africa. 2004 Environ 
Res; 96: 1-8
[75] Hauser R., Chen Z., Potheir L., 
Ryan L., Altshul L. The relationship 
between human semen parameters and 
environmental exposure to poly-
chlorinated biphenyls and p,p′-DDE. 
Environ Health Perspect. 2003; 111: 
1505-1511.
[76] Kruger T. et al., Xenoandrogenic 
activity in serum differs across Europe 
and Inuit populations. Environ Health 
Perspect. 2007; 115: 21-27
[77] Swan SH., Kruse RL., Liu F., et al., 
The study for future families research 
group. Semen quality in relation to 
biomarkers of pesticide exposure. 2003 
Environ Health Perspect;111: 1478-1484
[78] Marty SM., Singh NP., Holsapple MP., 
Gollapudi BB. Influence of p53 zygosity 
on select sperm parameters of the mouse. 
1999 Mutation Res;427:39-45
[79] Yin Y., Stahl BC., Dewolf WC., 
Morgentaler a. p53mediated germ cell 
quality control in spermatogenesis. 1998 
Dev Biol;204(1): 165-171
[80] Cruz FD., Lume C., Silva JV., 
Nunes A., Castro I., Silva R., Silva V., 
Ferreira R., Fardilha M. Oxidative stress 
markers: can they be used to evaluate 
human sperm quality? 2015 Turk J 
Urol;41(4):198-207
[81] Samplaski MK., 
Dimitromanolakis A., Lo KC., 
Grober ED., Mullen B., Garbens A., larvi 
KA. The relationship between sperm 
viability and DNA fragmentation rates. 
2015 Reprod Biol Endocrinol;13:42
[82] Fowler BA., Whittaker MH., 
Lipsky M., Wang G., Chen XQ. Oxidative 
stress induced by lead, cadmium and 
arsenic mixtures: 30-day, 90-day, and 
180-day drinking water studies in rats: an 
overview. 2004 Biometal; 17(5): 567-568
[83] Raimondo S., Gentile T., Cuomo F., 
De Filippo S., Aprea GE., Guida J. 
quantitative evaluation of p53 as a new 
indicator of DNA damage in human 
spermatozoa. 2014 J Hum Reprod Sci: 7 
(3); 212-217
[84] Gill P., Jeffreys AJ., Werrett DJ.: 
Forensic application of DNA 
‘fingerprints’. Nature 1985, 318:577-579
[85] Cassuto NG., Hazout A., 
Hammoud I., Balet R., Bouret D., 
Barak Y., Jellad S., Plouchart JS., 
Yazbeck C. Correlation between DNA 
defect and sperm-headmorfology 
(2012) ReproductiveBioMedicine 
Online;24:211-218
[86] Elbashir S., Magdi Y., Rashed A., 
Ahmedibrahim M., Edris Y, 
Abdelaziz AM. Relationship between 
sperm progressive motility and DNA 
integrity in fertile and infertile men. 
2018 Journal Middle East Fertility 
Society;23(3):195-198
[87] Aitken RJ., De Iuliis GN., 
Finnie JM., Hedges A., McLachlan RI. 
Analysis of the relationships between 
oxidative stress, DNA damage and 
sperm vitality in a patient population: 
development of diagnostic criteria. 
(2010) Hum Reprod; 25(10): 2415-2426
[88] Micic S., Lalic N., Djordjevic D., 
Bojanic N., Virmani A., Agarwal A. 
Sperm vitality and DNA fraagmentation 
index (DFI) are good predictors of 
progressive sperm motility in 
oligozooasthenospermic men treated 
with metabolic abd essential nutrients. 
2019 Hum Reprod; 33(3): 149-
[89] Agarwal A., Sharma R., Harlev A., 
Esteves SC. Effect of varicocele on 
P53 - A Guardian of the Genome and Beyond
24
semen characteristics according to the 
new 210 WHO criteria: A systematic 
rewiew and meta-analysis. 2016 Asian J 
Androl;18:163-170
[90] Aitken RJ., Fisher HM., Fulton N., 
Gomez E., Knox W., Lewis B., Irvine S. 
reactive oxygen species generation by 
human spermatozoa is induced by 
exogenous NADPH and inhibited by the 
flavoprotein inhibitors diphenylene 
iodonium and quinacrine. 1997 Mol 
Reprod Dev;47(4):468-482
[91] Mortimer D. Practical Laboratory 
Andrology. New York (USA): Oxford 
University Press.1994
[92] Griswold MD. Spermatogenesis: the 
commitment to meiosis. 2016 Physiol 
Rev; 96(1): 1-17
[93] Junqueira LC., Carneiro J. Compendio 
di istologia. 2006; Padova, Piccin V 
edizione
[94] Gonzalez-Mariscal L., Quiros M., 
Diaz-Coranguez M., Bautista P. Tight 
Junctions, Current Frontiers and 
perspectives in cell Biology. 2012: Edited 
by Stevo Najman, IntechOpen
[95] Mruk DD., Cheng CY. The 
mammalian blood-testis barrier: its 
biology and regulation. 2015 Endocrine 
Reviews;36(5):564-591
[96] Phillips BT., Gassei K., Orwig KE., 
Spermatogonial stem cell regulation and 
spermatogenesis. 2010 Phil Trans R Soc 
B; 365(1546): 1663– 1678
[97] Gu, J., Chen D., Rosenblum J., 
Rubin R., and Yuan Z. M. Identification 
of a sequence element from p53 that 
signals for Mdm2-targeted degradation. 
2000 Mol Cell Biol; 20: 1243-1253
[98] Rahman S., Lee JS., Kwon WS., 
Pang MG. Sperm proteomics: road to 
male fertility and contraception. 2013 
Int J Endocrinol Article; ID 
360986, 11pages
[99] Gebel J., Tuppi M., Krauskopf K., 
Coutandin D., Pitzius S., Kehrloesser S., 
Osterburg C., Dötsch V. Control 
mechanisms in germ cells mediated by 
p53 family proteins. 2017 Journal of Cell 
Science;130:2663-2267
[100] Gunes S., Al-Sadaan M., 
Agarwal A. Spermatogenesis, DNA 
damage and DNA repair mechanisms in 
male infertility. 2015 Reproductive 
BioMedicine Online;31:309-319
[101] Lane DP. Cancer. P53 guardian of 
the genome. 1992 Nature; 358:15-16
[102] Rotter, V., Schwartz, D., Almon, E., 
Goldfinger, N., Kapon, A., Meshorer, A., 
Donehower, L.A., Levine, a.J. mice with 
reduced levels of p53 exhibit the testicular 
giant cell degenerative syndrome. 1993 
PNAS; 90 (19): 9075-9079
[103] Chresta, C.M., Masters, J R. W., 
and Hickman, J.A. Hypersensitivity of 
human testicular tumors to etoposide-
induced apoptosis is associated with 
functional p53 and a high bax: bcl-2 
ratio. 1996 Cancer Res; 53: 1834-41
[104] Masters J.R.W., Osborne, E.J., 
Walker, M.C., and Parris, C. N. 
Hypersensitivity of human testis-tumor 
cell lines to chemotherapeutic drugs. 
1993 Int. J. Cancer; 53:340-346
[105] Socher SA., Yin Y., Dewolf, WC., 
Morgentaler, A. Temperature-mediated 
germ cell loss in the testis is associated 
with altered expression of the cell-cycle 
regulator p53. 1997 J Urol; 157: 1986-1989
[106] Olivier R. T. Testicular cancer. 1996 
Curr Opin Oncol; 8: 252-258
[107] Olivier, R. T. Testicular cancer. 1997 
Curr Opin Oncol; 9: 287-294
[108] Zamble, D. B., Jacks, T., and 
Lippard, S.J. p53dependent and 
independent responses to cisplatin in 
mouse testicular teratocarcinoma cells. 
1998 Proc. Natl Acad Sci; 95: 6163-6168
25
Presence of p53 Protein on Spermatozoa DNA: A Novel Environmental Bio-Marker and…
DOI: http://dx.doi.org/10.5772/intechopen.99559
[109] Lutzker, S. G., and Levine, A. J. A 
functionally inactive p53 protein in 
teratocarcinoma cells is activated by 
either DNA damage or cellular 
differentiation. 1996 Nat Med; 2: 804-810
[110] Gersten, K. M., and Kemp, C. J. 
Normal meiotic recombination in 
p53-deficient mice. 1997 Nat Genet; 
17:378-379
[111] Odorisio, T., Rodriguez TA., 
Evans EP., Clarke AR., Burgoyne PS. 
The meiotic checkpoint monitoring 
synapsis eliminates spermatocytes via 
p53-indipendent apoptosis. 1998 Nat 
Genet; 18: 257-261
[112] Katz DF., Overstreet JW. Sperm 
motility assessmente by videomicrografy. 
1981 Fert Steril;35(2):188-193
[113] Canale D., Giorgi PM., 
Gasperini M., Pucci E., Barletta D., 
Gasperi M., Martino E. Inter and 
Intra-Individual Variability of Sperm 
Morphology After Selection With Three 
Different Techniques: Layering, Swimup 
From Pellet and Percoll. 1994 J. 
Endocrinol Invest; 17(9):729-32
[114] Pinto S., Carrageta DF., Alves MG., 
Rocha A., Agarwal A., Barros A., 
Oliveira P. Sperma selection strategies 
and their impact on assisted reproductive 
technology outcomes. 2020 Andrologia; 
00:e13725
[115] Allahbadia GN., Gandhi G. et al. The 
art & Science of Assisted Reproductive 
Techniques (ART) Medical Ltd. 2017
[116] Anifandis G., Bounartzi C, 
Messini I, Dafopulos K, Sotiriou S, 
Messinis E. The impact of cigarette 
smoking and alcohol consumption on 
sperm parameters and sperm DNA 
fragmentation (sDF) measured by 
Halosperm. 2014 Archives of Gynecology 
and Obstetric, 290(4):777-782
[117] Kirsty A., Nisenblat V, Norman R. 
Lifestyle factors in people seeking 
infertility treatment – A review.2010 
Australian and New Zealand Journal of 
Obstetric and Gynecology;50(1):8-20
[118] La Vignera S., Condorelli R, 
Vicari E, D’Agata R, Calogero AE. 
Effects of varicocelectomy on sperm 
DNA fragmentation, mitochondrial 
function, chromatin condensation, and 
apoptosis. 2012 J Androl; 33:389-396
[119] Smit M., Romijn JC, Wildhagen MF, 
Veldhoven JL, Weber RF, Dohle GR. 
Decreased sperm DNA fragmentation 
after surgical varicocelectomy is 
associated with increased pregnancy 
rate. 2010 J Urol;183:270-274
[120] Wang YJ., Zhang RQ, Lin YJ, 
Zhang RG, Zhang WL. Relationship 
between and sperm DNA damage and 
the effect of varicocele repair: a meta-
analysis. 2012 Reprod Biomed online; 
25(3): 307-314
[121] Alahmar AT. Sperm motility using 
direct swim-up technique at two different 
temperatures. 2018 Gynecol Obstrt; 8:86
[122] Boomsma H. Semen preparation 
techniques for intrauterine insemination. 
Cochrane Database of Systematic 
Reviews. 2004
[123] Aitken RJ., Clarkson JS. Significance 
of reactive oxygen species ant 
antioxidants in defining the efficacy of 
sperm preparation techniques. 1988 J 
Androl; 9:367-376
[124] Volpes A., Sammartano F., 
Rizzari S., Gullo S., Marino A., Allegra A. 
The pellet swim-up is the best technique 
for sperm preparation during in vitro 
fertilization procedures. 2016 J Assist 
Reprod Genet; 33(6): 765-770
[125] Morshedi M. Efficacy and 
pregnancy outcome of two methods of 
semen preparation for intrauterine 
insemination: a prospective randomized 
study. 2003 Fert Steril;79 (3):1625-1632
P53 - A Guardian of the Genome and Beyond
26
[126] Xue X., Wang WS, Shi JZ, Zhang SL, 
Zhao WQ, Shi WH, Guo BZ, Qin Z. 
efficacy of swim-up versus density 
gradient centrifugation in improving 
sperm deformity rate and DNA 
fragmentation index in semen samples 
from teratozoospermic patients. 2014 J 
Assist Reprod Genet; 31(9):1161-1166
[127] Marchetti C., Gallego M.A., 
Deffosez A., Formstecher P.,Marchetti P. 
Staining of human sperm with 
fluorochrome-labeled inhibitor of 
caspases to detect activated caspases: 
Correlation with apoptosis and sperm 
parameters. 2004 Hum Reprod;19: 
1127-1134
[128] Said T., Agarwal T., Grunewald S., 
Rasch M., Baumann T. and Kriegel C. et 
al. Selection of nonapoptotic spermatozoa 
as a new tool for enhancing assisted 
reproduction outcomes: an in vitro model 
2006 Biol Reprod; 74: 530-537
[129] Raimondo S., Gentile T., 
Gentile M., Donnarumma F., 
Esposito G., Morelli A., De Filippo S., 
Cuomo F. comparing different sperm 
separation techniques for ART, through 
quantitative evaluation of p53 protein. 
2020 J Hum Reprod Sci; 13(2): 117-124
[130] Levine AJ., Tomasini R., 
McKeon FD., Mak TW. The p53 family: 
guardians of maternal reproduction. 2011 
Nat Rev Mol Cell Biol, 12(4), 259-265
[131] Chandrakanthan V., Li A., Chami O., 
O’Neill C. Effects of in vitro fertilization 
and embryo culture on TRP53 and Bax 
expression in B6 mouse embryos. 2006 
Reprod Biol Endocrinol;4, 61-70
[132] Li A., Chandrakanthan V., Chami O., 
O’Neill C. culture of zygotes increases 
Trp53 [corrected] expression in B6 mouse 
embryos, which reduces embryo viability. 
2007 Biol Reprod; 76(3): 362-367
[133] Hanson HA., Mayer EN., 
Anderson RE., Aston KI., Carrel DT., 
Berger J., Lowrance WT., Smith KR., 
Hotaling JM. Risk of childhood mortality 
in family members of men with poor 
semen quality. 2017 Hum Reprod; 
22(1) 239-247
[134] Raimondo S., Notari T., Gentile M., 
Cirmeni M., Gentile T., Montano L., 
Borsellino G. level of p53 protein in 
human spermatozoa, embryo quality 
and pregnancy rate. EcoFoodFertility 
project (preliminary data). 2018 Hum 
Reprod;22:85
